Western blot analysis confirmed that treatment with Afatinib attenuated the expression of phosphorylated EGFR and SCH attenuated the expression of CXCR1/2, and revealed that both SCH and Afatinib downregulated phospho‐ERK1/2 expression (Figure 2F). Here, EGFR is linked to spindle cell hemangioma.